| Accession |
PRJCA021099 |
| Title |
An open, multicenter Phase II clinical study of pyrrotinib maleate combined with docetaxel in first-line treatment of HER2-positive metastatic breast cancer(MA-BC-II-001) |
| Relevance |
Medical |
| Data types |
Nucleic acid biomarker data
|
| Organisms |
Homo sapiens
|
| Description |
An open, multicenter Phase II clinical study of pyrrotinib maleate combined with docetaxel in first-line treatment of HER2-positive metastatic breast cancer |
| Sample scope |
Multiisolate |
| Release date |
2023-11-07 |
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| NA
|
NA
|
NA
|
|
|
|
| Submitter |
weiqing ge
weiqing
ge (weiqing.ge@hengrui.com)
|
| Organization |
Jiangsu Hengrui pharmaceutical Co.LTD |
| Submission date |
2023-11-07 |
